106 related articles for article (PubMed ID: 12430178)
1. Inhibition of progesterone-induced VEGF production in human breast cancer cells by the pure antiestrogen ICI 182,780.
Hyder SM; Stancel GM
Cancer Lett; 2002 Jul; 181(1):47-53. PubMed ID: 12430178
[TBL] [Abstract][Full Text] [Related]
2. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.
Wu J; Richer J; Horwitz KB; Hyder SM
Cancer Res; 2004 Mar; 64(6):2238-44. PubMed ID: 15026368
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia reduces hormone responsiveness of human breast cancer cells.
Kurebayashi J; Otsuki T; Moriya T; Sonoo H
Jpn J Cancer Res; 2001 Oct; 92(10):1093-101. PubMed ID: 11676860
[TBL] [Abstract][Full Text] [Related]
4. Complex agonist-like properties of ICI 182,780 (Faslodex) in human breast cancer cells that predominantly express progesterone receptor-B: implications for treatment resistance.
Wu J; Liang Y; Nawaz Z; Hyder SM
Int J Oncol; 2005 Dec; 27(6):1647-59. PubMed ID: 16273221
[TBL] [Abstract][Full Text] [Related]
5. Regulation of vascular endothelial growth factor expression by estrogens and progestins.
Hyder SM; Huang JC; Nawaz Z; Boettger-Tong H; Mäkelä S; Chiappetta C; Stancel GM
Environ Health Perspect; 2000 Oct; 108 Suppl 5():785-90. PubMed ID: 11035983
[TBL] [Abstract][Full Text] [Related]
6. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells.
Hyder SM; Chiappetta C; Stancel GM
Int J Cancer; 2001 May; 92(4):469-73. PubMed ID: 11304678
[TBL] [Abstract][Full Text] [Related]
8. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Hyder SM; Murthy L; Stancel GM
Cancer Res; 1998 Feb; 58(3):392-5. PubMed ID: 9458078
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells.
Ruohola JK; Valve EM; Karkkainen MJ; Joukov V; Alitalo K; Härkönen PL
Mol Cell Endocrinol; 1999 Mar; 149(1-2):29-40. PubMed ID: 10375015
[TBL] [Abstract][Full Text] [Related]
11. Is ICI 182,780 an antiprogestin in addition to being an antiestrogen?
Rosenberg Zand RS; Grass L; Magklara A; Jenkins DJ; Diamandis EP
Breast Cancer Res Treat; 2000 Mar; 60(1):1-8. PubMed ID: 10845803
[TBL] [Abstract][Full Text] [Related]
12. Induction of the angiogenic factor VEGF in the uterus by the antiprogestin onapristone.
Hyder SM; Chiappetta C; Stancel GM
Cancer Lett; 2000 Aug; 156(1):101-7. PubMed ID: 10840165
[TBL] [Abstract][Full Text] [Related]
13. Treatment with the pure antiestrogen faslodex (ICI 182780) induces tumor necrosis factor receptor 1 (TNFR1) expression in MCF-7 breast cancer cells.
Smolnikar K; Löffek S; Schulz T; Michna H; Diel P
Breast Cancer Res Treat; 2000 Oct; 63(3):249-59. PubMed ID: 11110059
[TBL] [Abstract][Full Text] [Related]
14. Cyr61 promotes breast tumorigenesis and cancer progression.
Tsai MS; Bogart DF; Castañeda JM; Li P; Lupu R
Oncogene; 2002 Nov; 21(53):8178-85. PubMed ID: 12444554
[TBL] [Abstract][Full Text] [Related]
15. Enhanced epidermal growth factor receptor signaling in MCF7 breast cancer cells after long-term culture in the presence of the pure antiestrogen ICI 182,780 (Faslodex).
McClelland RA; Barrow D; Madden TA; Dutkowski CM; Pamment J; Knowlden JM; Gee JM; Nicholson RI
Endocrinology; 2001 Jul; 142(7):2776-88. PubMed ID: 11415996
[TBL] [Abstract][Full Text] [Related]
16. Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cells.
Gaddy VT; Barrett JT; Delk JN; Kallab AM; Porter AG; Schoenlein PV
Clin Cancer Res; 2004 Aug; 10(15):5215-25. PubMed ID: 15297425
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor in primate endometrium is regulated by oestrogen-receptor and progesterone-receptor ligands in vivo.
Greb RR; Heikinheimo O; Williams RF; Hodgen GD; Goodman AL
Hum Reprod; 1997 Jun; 12(6):1280-92. PubMed ID: 9222018
[TBL] [Abstract][Full Text] [Related]
18. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.
Wu J; Brandt S; Hyder SM
Mol Endocrinol; 2005 Feb; 19(2):312-26. PubMed ID: 15528272
[TBL] [Abstract][Full Text] [Related]
19. The pure antiestrogen ICI 182,780 inhibits progestin-induced transcription.
Nawaz Z; Stancel GM; Hyder SM
Cancer Res; 1999 Jan; 59(2):372-6. PubMed ID: 9927049
[TBL] [Abstract][Full Text] [Related]
20. Effects of 17beta-estradiol, progesterone, synthetic progestins, tibolone, and raloxifene on vascular endothelial growth factor and Thrombospondin-1 messenger RNA in breast cancer cells.
Mirkin S; Wong BC; Archer DF
Int J Gynecol Cancer; 2006; 16 Suppl 2():560-3. PubMed ID: 17010073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]